Table 2 Clinical characteristics according to AIP quartiles among all participants

 Age, years

32 (29–34)

32 (30–35)

32 (31–35)

32 (31–35)

<0.001

 Male, n(%)

299 (81.03)

352 (95.14)

360 (97.30)

362 (98.10)

<0.001

 BMI, kg/m²

25.62 ± 4.73

27.75 ± 4.41

28.72 ± 4.18

28.89 ± 3.44

<0.001

 Smoker, n(%)

176 (47.70)

253 (68.38)

279 (75.41)

296 (80.22)

<0.001

 EH, n(%)

101 (27.37)

123 (33.24)

138 (37.30)

149 (40.38)

<0.001

 DM, n(%)

13 (3.52)

28 (7.57)

42 (11.35)

59 (15.99)

<0.001

 TC, mmol/L

4.20 ± 1.26

4.42 ± 1.36

4.59 ± 1.15

5.11 ± 1.46

<0.001

 TG, mmol/L

0.99 (0.75–1.18)

1.52 (1.32–1.77)

2.18 (1.87–2.47)

3.77 (3.06–4.99)

<0.001

 HDL-C, mmol/L

1.14 ± 0.25

0.95 ± 0.17

0.83 ± 0.17

0.82 ± 0.17

<0.001

 LDL-C, mmol/L

2.65 ± 1.17

2.93 ± 1.24

3.02 ± 0.99

2.94 ± 1.06

<0.001

 ACS, n (%)

210 (56.91)

271 (73.24)

282 (76.22)

296 (80.22)

<0.001

 AMI, n (%)

106 (28.73)

154 (41.62)

169 (45.68)

177 (47.97)

<0.001

 UAP, n (%)

104 (28.18)

117 (31.62)

113 (30.54)

119 (32.25)

<0.001

 GS

5 (0–32)

16 (0–44.75)

20 (0–48.5)

25 (3–56)

<0.001